Unexpected PLGA results often appear first in device data: a molecular-weight shift after extrusion, a release profile that changes after sterilization, a scaffold that loses structure earlier than expected, or a degradation study that no longer matches a previous build.

In these situations, incoming material data provides the baseline for investigating these changes. It describes the polymer state at release, before device processing introduces additional thermal, chemical, or environmental history. That baseline doesn't capture what happens after the material enters the development process, though.

Processing creates a second history. Exposure to heat or moisture can change the polymer before fabrication is complete. Solvent-based processing can alter morphology through the way the solvent is removed, and sterilization can introduce another source of molecular-weight loss. Storage between steps may add further exposure that is easy to overlook.

These changes become visible through the finished device. A shift in structure may appear as earlier loss of strength. A change in morphology may alter release behavior or dimensional stability. Differences in device geometry can also change the apparent degradation response, even when the starting polymer specification is unchanged.

Troubleshooting therefore begins with the sequence of operations used to make and test the device. The goal is to identify where the polymer state, device morphology, or geometry diverged from the earlier build.

Recent PLGA implant literature continues to examine how polymer state, manufacturing history, and device format interact to influence performance.[1] The development issues below are among the most common reasons PLGA data becomes difficult to interpret.

1. Incoming material data may not describe the polymer inside the device

A release specification establishes the starting material state, though it doesn't describe the polymer after fabrication has added heat history, moisture exposure, solvent contact, sterilization, storage time, or geometry-specific degradation conditions.

As Sean Moore, Vice President of Sales at Polysciences, notes, “The material may meet the specification but behave differently in the customer’s process or device.” A certificate of analysis may include inherent viscosity, molecular-weight range, composition, residual solvent, residual monomer, and other release attributes. Those values remain important, but they should be interpreted as the beginning of the device workflow rather than a complete description of the finished article.

By the time PLGA is present in a molded component, coating, porous scaffold, or drug-loaded matrix, it may carry a different material history from the incoming resin.

2. Processing can change molecular weight before testing begins

PLGA is a hydrolytically degradable polyester. Moisture, elevated temperature, extended residence time, and demanding thermal or mechanical processing conditions can alter the polymer before a degradation or performance study begins.

A 2025 study of PLGA melts reported that residual water and chain-end groups accelerated degradation under the tested thermal conditions.[2] The exact findings should not be generalized to every device, but the mechanism-level concern is broadly relevant: moisture and heat exposure can change the polymer state during processing.

This is especially important for extrusion, injection molding, hot-melt processing, solvent casting, solvent-based coating, and some additive-manufacturing routes. Incoming inherent viscosity or molecular weight provides the baseline; post-processing IV or GPC data may be needed when fabrication itself could contribute to chain scission or molecular-weight loss.

3. Moisture, residual solvent, and storage can become device variables

Moisture exposure becomes part of PLGA process history because absorbed water can initiate ester hydrolysis before the device enters formal degradation testing. The effect may be small at room temperature and still become significant during a later thermal step, when chain scission proceeds more rapidly. Drying therefore needs to be evaluated in relation to the full sequence that follows it. A material that meets a moisture limit immediately after drying may not represent the same polymer state after transfer, hold time, or storage in a package with insufficient barrier performance.

Residual solvent affects the system through a different mechanism. Solvent retained within the polymer can change chain mobility and influence how the matrix reorganizes as drying continues. In microparticles, this can alter the way pores form, the degree to which particles fuse or aggregate, and the distribution of drug within the polymer phase. These structural changes may persist after the residual-solvent concentration has fallen, which helps explain why two batches with similar final solvent values can still produce different release profiles.

Recent studies on PLGA microparticles have shown that extraction and drying conditions affect more than the amount of solvent remaining in the product. The solvent-removal pathway also changes the particle structure that develops during hardening, with downstream effects on loading and release.[3][4] Those findings should not be generalized to every PLGA device format, but they illustrate why solvent history cannot be reduced to a single residual-solvent result at the end of processing.

The same reasoning applies after fabrication. A device can continue to change during the period between manufacture and testing, especially when the polymer remains sensitive to moisture or when residual solvent is still redistributing through the matrix. Storage limits therefore need to be tied to evidence that the polymer state and device response remain stable over the proposed hold period. The key question to answer is whether the material entering performance testing is still equivalent to the material produced at the end of fabrication.

4. Sterilization should be evaluated early

Sterilization should be incorporated before the development program becomes anchored to the nonsterile article. In a PLGA device, sterilization can alter the material state established during fabrication, so its effect cannot be separated from the polymer and device configuration being tested. The same method may produce different consequences when the grade, geometry, or packaging changes, and the significance of those changes depends on the function the device must retain.

A 2025 study of PLGA films reported molecular-weight reduction after both low-energy electron irradiation and gamma irradiation under the conditions examined.[5] The film model doesn't establish how every implant will respond; however, it does show that irradiation can change the polymer before the device enters aging or performance testing. Characterization therefore needs to be performed in a format that captures the thermal history, dimensions, and physical structure of the actual article.

The appropriate measurements follow from the device’s failure mode. In a fixation component, sterilization-related molecular-weight loss may become relevant when it shortens the period over which the part retains load-bearing capacity. In a drug-eluting system, the same change may alter matrix transport or destabilize the coating structure, producing a release profile that no longer matches the nonsterile build. A porous scaffold introduces another concern because changes in polymer integrity can affect both structural support and the architecture through which fluid enters the device.

For that reason, post-sterilization testing should reproduce the decisions the development team will later make from the data. Pre-sterilization results can't establish retained performance when sterilization itself may change the polymer state.

5. Geometry can change the degradation environment

Device geometry changes the transport conditions under which PLGA degrades. In a thin article, water can penetrate the matrix and soluble degradation products can leave over relatively short distances. As thickness increases, diffusion becomes less efficient relative to the volume of polymer undergoing hydrolysis. Acidic oligomers may then remain within the interior long enough to accelerate local chain scission, creating a degradation pattern that differs from the surface.

Porosity changes that balance again. An interconnected pore network increases fluid access to the polymer and shortens some diffusion paths, although the result depends on whether the pores remain open as the structure changes. Dense regions can retain degradation products more readily, whereas highly accessible regions may lose mass earlier. The device can therefore develop spatial differences in molecular weight and mechanical integrity even when it was fabricated from a uniform starting material.

These transport effects also help explain why the same PLGA grade can produce different release profiles across device formats. A coating places much of the polymer close to an external interface, while a drug-loaded matrix may require water and dissolved drug to move through a longer internal path. Changes in thickness or internal structure can shift the relative contributions of diffusion, polymer relaxation, pore formation, and erosion. A 2025 review of PLGA-based release mechanisms similarly identifies device dimensions and geometry, together with manufacturing conditions and the surrounding environment, as contributors to release behavior.[6]

Simplified coupons remain useful when the purpose is to compare materials under controlled conditions. Their predictive value decreases once the final device introduces a different transport length or internal architecture. At that stage, degradation and release data need to be generated in a format that reproduces the physical pathways present in the intended article.

6. Scale-up can change the polymer’s exposure history

Scale-up often exposes PLGA process sensitivity because larger equipment changes the conditions the polymer actually experiences, even when the process sequence remains nominally unchanged. An extrusion step may use the same target temperature, yet a longer residence time or slower cooling profile can increase cumulative thermal exposure. A drying step may meet the same endpoint specification while removing moisture less uniformly across a larger batch.

These differences can carry forward into the device. Additional heat or shear may reduce molecular weight before molding is complete, while changes in solvent-removal kinetics can alter how the polymer phase consolidates, leaving a different internal structure even when the final residual-solvent result is similar. Longer transfers or equipment holds may also allow moisture uptake before the next processing step.

This creates a common scale-up problem: the bench and production processes appear equivalent in the batch record, but the resulting articles don't share the same material history. The most informative comparison is usually made across the sequence itself. Material collected after drying can show whether the shift occurred before fabrication. Measurements taken after the main thermal or solvent step can indicate whether processing changed chain length or morphology. Later results can then determine whether sterilization or storage added a further change.

The investigation doesn't require every attribute to be measured at every stage. Testing should follow the output that moved. A loss in mechanical retention may justify tracking molecular weight through the process, whereas a release shift may require closer examination of morphology or solvent-removal history. This approach narrows the investigation to the point where scale-up first changed the state of the polymer or the structure of the device.

Troubleshooting PLGA data shifts

Observed shift	Areas to investigate
If IV or molecular weight changed	Review drying, moisture exposure, processing temperature, residence time, thermal and mechanical history, solvent exposure, and sterilization. Compare incoming and post-processing polymer data where possible.
If degradation is faster than expected	Review molecular weight after processing, moisture exposure, sterilization, geometry, thickness, porosity, and whether the degradation article reflects the final device.
If mechanical retention changes	Review processing temperature, molecular weight after fabrication, sterilization, geometry, aging conditions, and whether the test article reflects the final load-bearing structure.
If release behavior shifts	Review residual solvent, morphology, coating integrity, drug distribution, water uptake, sterilization, and storage history.
If scale-up changes the result	Compare residence time, heat transfer, drying efficiency, solvent removal, cooling rate, hold time, and ambient exposure across scales.

What to measure when PLGA data moves

Start with the device result that changed and work backward. If inherent viscosity or molecular weight drops after a processing step, chain scission is a reasonable concern. Comparing the material before and after that step can help show whether the change occurred during drying, thermal processing, or sterilization.

A release shift does not always track with molecular-weight loss. When IV or GPC results remain comparable, the next place to look is usually the structure created during fabrication. Solvent-removal conditions can affect how the polymer phase consolidates, and those differences may appear as changes in pore formation, coating continuity, or drug distribution. Residual-solvent measurements can support that investigation, although the final solvent value may not capture structural changes established earlier in the drying process.

Mechanical changes need to be evaluated in the finished or near-finished geometry. Polymer-level data can help explain a loss in strength retention, but it cannot show how the complete device carries load after fabrication, sterilization, and aging. The same limitation applies to degradation studies. Mass loss and water uptake are most informative when the test article reproduces the dimensions and transport pathways of the intended device.

The useful measurement is the one that separates the most plausible explanations for the observed shift. A broad analytical panel may generate more data without showing where the process first changed the polymer or device structure.

Final considerations

Many PLGA development problems become easier to interpret once the investigation moves beyond the incoming specification and reconstructs the material state of the device at the point of testing. Starting with the output that changed and working backward through the process can identify where the first meaningful divergence occurred.

References

[1] Das, S.; Seesala, V. S.; Basu, B.; Mukherjee, S. “PLGA-based resorbable implants for biomedical applications: manufacturing, biocompatibility, and clinical translation.” Materials Today Communications, 2025.

[2] Chen, B.; Costello, M. A.; Kuehster, L.; Lynd, N. A.; Qin, B.; Wang, Y.; Zhang, F. “Investigation of the Thermal Stability and Hydrolytic Degradation Kinetics of Poly(Lactide-co-Glycolide) Melts.” AAPS PharmSciTech, 2025.

[3] Kias, F.; Bodmeier, R. “Acceleration of Final Residual Solvent Extraction From Poly(lactide-co-glycolide) Microparticles.” Pharmaceutical Research, 2024.

[4] “Accelerated removal of solvent residuals from PLGA microparticles by alcohol vapor-assisted fluidized bed drying.” International Journal of Pharmaceutics, 2024.

[5] “How to sterilize biodegradable polymers? An in-depth characterization of effects of low energy electron beam irradiation (LEEI) and gamma irradiation on the molecular weight of poly(lactide-co-glycolide) films.” International Journal of Pharmaceutics, 2025.

[6] “Release mechanisms of PLGA-based drug delivery systems: A review.” Journal of Controlled Release: X, 2025.